WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the creation of a Scientific Advisory Board to provide counsel and ...

Opko Health Inc. (NASDAQ:OPK) is one of the 13 Best Long-Term Penny Stocks to Buy According to Analysts. In a report released ...

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise ...

OPKO Health, Inc. (NASDAQ: OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the ...

OPKO Health, Inc. Conference call begins at 4:30 p.m. Eastern time today. MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial ...

Shares of Opko Health have decreased by 27.39% in the past year. An investor who bought shares of Opko Health at the beginning of the year would take a loss of $0.03 per share if they sold it today.

OPKO received last December a $295 million upfront payment from Pfizer as part of a long-term agreement for the commercialization of Lagova hGH-CTP, ...

What: Shares of Opko Health , a biopharmaceutical and diagnostics company aiming to treat a variety of diseases and disorders, were slammed and sank as much as 15% on Thursday after the company ...

OPKO has $265.6M in receivables and $97M in inventory. Its $283M short-term and $370M in long-term liabilities are covered. Free cash flow leaves OPKO with a cash runway for the next three years.

This week's technology and ventures news. Opko Health CEO Dr. Phillip Frost appeared on Bloomberg TV Jan. 30 and shared insights on the Miami biotechnology company’s ups and downs, what lies ...